Jefferies analyst Tycho Peterson maintains $Thermo Fisher Scientific (TMO.US)$ with a buy rating, and maintains the target price at $655.
According to TipRanks data, the analyst has a success rate of 54.9% and a total average return of 7.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Thermo Fisher Scientific (TMO.US)$'s main analysts recently are as follows:
Thermo Fisher's recent quarterly results met expectations in a context where anticipation was high. The company is recognized for its robust performance within a challenging demand climate for tools, where there is limited clarity on when a recovery in demand will materialize.
The recent third-quarter earnings call for Thermo Fisher was noted to be more optimistic than the actual results presented. Despite this, there remains a positive outlook on the company's stock. Observations include that the Life Sciences Solutions segment continues to experience momentum in bioproduction, and sales within the Laboratory Products and Biopharma Services segment appear unfazed by a slowdown in biotech.
Thermo Fisher's core growth exhibits a steady improvement on a quarter-over-quarter basis, with guidance suggesting a modest increase to around 2.5% in the fourth quarter. Expectations for a 5% core growth in 2025 appear reasonable and justifiable. The company's defensive profile and balance sheet flexibility continue to be favorable aspects.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
富瑞集團分析師Tycho Peterson維持$賽默飛世爾 (TMO.US)$買入評級，維持目標價655美元。
根據TipRanks數據顯示，該分析師近一年總勝率為54.9%，總平均回報率為7.1%。
此外，綜合報道，$賽默飛世爾 (TMO.US)$近期主要分析師觀點如下：
賽默飛世爾最近季度業績符合預期，預期高漲的背景下。該公司以在需求氣候嚴峻的情況下表現強勁而聞名，目前關於需求何時復甦尚無明確的說法。
最近的第三季度業績會顯示，賽默飛世爾的表現比實際結果所呈現的更爲樂觀。儘管如此，對該公司股票仍持樂觀態度。觀察表明，生命科學解決方案部門在生物生產方面持續勢頭強勁，實驗室產品和生物製藥服務部門的銷售似乎並未受生物技術行業放緩的影響。
賽默飛世爾的核心增長在季度間持續穩步改善，指導建議第四季度將略有增長，約爲2.5%。對2025年5%核心增長的預期似乎是合理且有理由的。公司的防禦性特點和資產負債表靈活性繼續是有利的方面。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
